![cdc-update](/sites/default/files/2018-07/cdc-update.jpg)
The Food and Drug Administration this week released guidance for institutional review boards seeking clarity regarding the key factors and procedures they should consider when reviewing requests by physicians and others for individual patient access to investigational drugs.